Profil
Matthew Trudeau worked as the Head of the U.S.
Business Team at Bluebird Biosciences, Inc. from 2016 to 2021.
He also worked as the Chief Commercial Officer at Vascular Biogenics Ltd.
in 2022.
Prior to his professional experience, he obtained an undergraduate degree from Colby College and a graduate degree from Northeastern University.
Anciens postes connus de Matthew Trudeau
| Sociétés | Poste | Fin |
|---|---|---|
| NOTABLE LABS, LTD. | Corporate Officer/Principal | 01/08/2022 |
| Bluebird Biosciences, Inc. | Corporate Officer/Principal | 01/01/2021 |
Formation de Matthew Trudeau
| Colby College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| Bluebird Biosciences, Inc. | |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
